Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
24.16
+0.16 (0.67%)
At close: Nov 6, 2026, 4:00 PM EST
24.20
+0.04 (0.17%)
After-hours: Nov 6, 2026, 7:58 PM EST
Veracyte Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 581.78 | 517.15 | 445.76 | 361.05 | 296.54 | 219.51 | |
Revenue Growth | 17.50% | 16.01% | 23.46% | 21.76% | 35.09% | 86.85% |
Cost of Revenue | 150.34 | 143.95 | 136.07 | 112.9 | 101.58 | 74.4 |
Gross Profit | 431.45 | 373.2 | 309.7 | 248.15 | 194.95 | 145.11 |
Selling, General & Admin | 221.04 | 226.24 | 203.88 | 193.1 | 170.61 | 180.38 |
Research & Development | 109.55 | 70.81 | 69.29 | 57.31 | 40.6 | 29.84 |
Amortization of Goodwill & Intangibles | 13.46 | 13.15 | 14.85 | 20.57 | 21.35 | 15.98 |
Operating Expenses | 344.05 | 310.21 | 288.02 | 270.98 | 232.56 | 226.21 |
Operating Income | 87.4 | 62.99 | 21.68 | -22.83 | -37.61 | -81.09 |
Interest Expense | - | -0 | -0 | -0.02 | -0.2 | -0.24 |
Interest & Investment Income | 15.41 | 12.72 | 11.15 | 7.34 | 1.97 | 0.14 |
Currency Exchange Gain (Loss) | -0.37 | 3.97 | -2.05 | 0.72 | 0.2 | -1.08 |
Other Non Operating Income (Expenses) | 3.83 | 0.44 | 0.5 | 1.13 | 2.68 | 1.44 |
EBT Excluding Unusual Items | 106.26 | 80.12 | 31.28 | -13.65 | -32.96 | -80.84 |
Gain (Loss) on Sale of Assets | - | -6.71 | - | - | - | - |
Asset Writedown | - | -20.51 | -3.37 | -68.35 | -3.32 | - |
Other Unusual Items | 13.69 | 15.3 | -2.17 | 5.38 | -0.15 | -0.81 |
Pretax Income | 118.25 | 68.2 | 25.74 | -76.61 | -36.43 | -81.65 |
Income Tax Expense | -8.6 | 1.85 | 1.61 | -2.21 | 0.13 | -6.09 |
Net Income | 126.85 | 66.35 | 24.14 | -74.4 | -36.56 | -75.56 |
Net Income to Common | 126.85 | 66.35 | 24.14 | -74.4 | -36.56 | -75.56 |
Net Income Growth | 318.41% | 174.89% | - | - | - | - |
Shares Outstanding (Basic) | 80 | 79 | 76 | 73 | 72 | 68 |
Shares Outstanding (Diluted) | 82 | 81 | 78 | 73 | 72 | 68 |
Shares Change | 2.68% | 3.08% | 7.60% | 1.53% | 5.39% | 27.52% |
EPS (Basic) | 1.59 | 0.84 | 0.32 | -1.02 | -0.51 | -1.11 |
EPS (Diluted) | 1.53 | 0.82 | 0.31 | -1.02 | -0.51 | -1.11 |
EPS Growth | 302.55% | 164.52% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 161.95 | 126.63 | 63.81 | 34.26 | -1.01 | -37 |
Free Cash Flow Per Share | 1.97 | 1.57 | 0.82 | 0.47 | -0.01 | -0.55 |
Gross Margin | 74.16% | 72.17% | 69.48% | 68.73% | 65.74% | 66.11% |
Operating Margin | 15.02% | 12.18% | 4.86% | -6.32% | -12.68% | -36.94% |
Profit Margin | 21.80% | 12.83% | 5.42% | -20.61% | -12.33% | -34.42% |
Free Cash Flow Margin | 27.84% | 24.49% | 14.31% | 9.49% | -0.34% | -16.85% |
EBITDA | 108.94 | 84.4 | 45.14 | 4.36 | -11.68 | -61.5 |
EBITDA Margin | 18.73% | 16.32% | 10.13% | 1.21% | -3.94% | -28.02% |
D&A For EBITDA | 21.55 | 21.42 | 23.46 | 27.19 | 25.93 | 19.59 |
EBIT | 87.4 | 62.99 | 21.68 | -22.83 | -37.61 | -81.09 |
EBIT Margin | 15.02% | 12.18% | 4.86% | -6.32% | -12.68% | -36.94% |
Effective Tax Rate | - | 2.71% | 6.24% | - | - | - |
Revenue as Reported | 581.78 | 517.15 | 445.76 | 361.05 | 296.54 | 219.51 |